-
Mashup Score: 6
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized weight loss management, and researchers are now exploring how these medications can further transform obesity care and offer new possibilities for long-term weight management, according to a recent review article published in Endocrinology. Authors Lauren A. Jones and Daniel I. Brierley, PhD, both of the Centre for Cardiovascular…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1
On March 13, the Board of Trustees of the University of Pennsylvania voted unanimously to appoint Endocrine Society Past-President J. Larry Jameson, who has served as interim president since December 2023, president of the University for a term that will run through June 30, 2027. In announcing the appointment, Chair of the Board of Trustees…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Members in the News @TheEndoSociety Past-President, J. Larry Jameson's @penn presidency unanimously extended to 2027: https://t.co/IYqzukWcq8
-
-
Mashup Score: 0
Leading pediatric endocrinologist and recipient of the Endocrine Society’s 2025 Outstanding Leadership in Endocrinology Laureate Award, Ilene Fennoy, MD, talks with Endocrine News about the potential of GLP-1s and long-term solutions for childhood obesity. She says a good place to start is creating more programs in schools to help kids eat better and incorporate more…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
We talk with the 2025 @TheEndoSociety Outstanding Leadership in Endocrinology Laureate Award winner, Ilene Fennoy, MD, who discusses the potential of GLP-1s and long-term solutions for childhood obesity: https://t.co/BTGiU3cMc5 https://t.co/HjNPvfY2Fh
-
-
Mashup Score: 0Pharma Fridays - March 7, 2025 - Endocrine News - 24 day(s) ago
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Celltrion Receives U.S. FDA Approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) Biosimilars Referencing PROLIA® and XGEVA® On March 3, Celltrion announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) and OSENVELT® (CT-P41, denosumab-bmwo), biosimilars referencing PROLIA® (denosumab) and XGEVA® (denosumab) respectively…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Pharma Friday - March 7, 2025 An update from @Celltrioninc regarding an @US_FDA approval for two biosimilars: https://t.co/in5TVnTSDR
-
-
Mashup Score: 0McDonnell Receives 2025 Baxter Prize - Endocrine News - 2 month(s) ago
Donald Patrick McDonnell, PhD, has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer, the Society announced today. The John D. Baxter Prize for Entrepreneurship was established to recognize the extraordinary achievement of bringing an idea, product, service, or process to market. This…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Congratulations to Donald Patrick McDonnell, PhD, been awarded @TheEndoSociety's John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer. https://t.co/xsZneBjPtJ https://t.co/KdskSIRxh6
-
-
Mashup Score: 6
We grow as professionals by staying informed on emerging research and developments in our field. As your professional home, the Society offers a variety of resources to help you keep pace with the latest trends and cutting-edge science and clinical practice. No matter what time zone you live in, no matter how you prefer to…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
.@TheEndoSociety offers several resources to help you keep pace with the latest trends and cutting-edge science and clinical practice. Regardless of your time zone, no matter how you prefer to stay connected, we have the tools to keep you informed. https://t.co/YXUBhbmxuw
-
-
Mashup Score: 11High Time: Addressing Research Gaps in Opioid-Associated Endocrine Conditions - Endocrine News - 2 month(s) ago
Endocrine News speaks with Niki Karavitaki, MSc, PhD, FRCP, of the University of Birmingham, Birmingham Health Partners, and the University Hospitals Birmingham National Health Service Foundation Trust in Birmingham, U.K., chair of the Endocrine Society’s recent Scientific Statement on opioids’ impact on the endocrine system. She discusses gaps in research, as well as why healthcare…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
.@Karavitaki_Niki, lead author of the @TheEndoSociety Scientific Statement on #opioids’ impact on the #endocrine system, discusses gaps in research, as well as why healthcare professionals should be aware of opioid-induce endocrinopathies: https://t.co/39dLn03fdF
-
-
Mashup Score: 4Yo-Yo Dieting May Significantly Increase Kidney Disease Risk in People with Type 1 Diabetes - Endocrine News - 2 month(s) ago
Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other traditional risk factors, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Yo-yo dieting is defined…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Yo-yo dieting can significantly increase the risk of kidney disease in people with type 1 diabetes, regardless BMI, according to a new study published in @TheEndoSociety's Journal of Clinical Endocrinology & Metabolism: https://t.co/BQU1RmZiRn
-
-
Mashup Score: 1Call for Abstracts - 2 month(s) ago
There is no better place to share your research than ENDO, the Endocrine Society’s annual meeting. Submitting an abstract earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive patient care for the people that need us most. All accepted abstracts will also be published in a supplement to our Open Access publication, Journal of the Endocrine Society (JES) and assigned a DOI. Abstract Submission period: December 5, 2024 – January 30,
Source: www.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Abstract submissions for ##ENDO2025 open this Thursday Dec. 5 at 11 a.m.! Submit your groundbreaking science and we'll see you in San Francisco in July! https://t.co/YyvbluYBXh
-
-
Mashup Score: 1Call for Abstracts - 2 month(s) ago
There is no better place to share your research than ENDO, the Endocrine Society’s annual meeting. Submitting an abstract earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive patient care for the people that need us most. All accepted abstracts will also be published in a supplement to our Open Access publication, Journal of the Endocrine Society (JES) and assigned a DOI. Abstract Submission period: December 5, 2024 – January 30,
Source: www.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Abstract submissions for ##ENDO2025 open this Thursday Dec. 5 at 11 a.m.! Submit your groundbreaking science and we'll see you in San Francisco in July! https://t.co/YyvbluYBXh
-
A review article from @TheEndoSociety's Endocrinology journal explores how GLP-1RAs can further transform #obesity care and offer new possibilities for long-term weight management https://t.co/CRvTl4ty5c https://t.co/fYe7fxWOmu